24 reports

BLOOD PRODUCTS INDUSTRY ASSESSMENTS Chart ##: China' s Key Blood Products Producer Location by Province Chapter III ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ##

  • Hepatitis
  • China
  • Chengdu Ronsen Pharmaceutical Co., Ltd.
  • Hualan Biological Engineering Co., Ltd.
  • Ltd. Hualan Biological Engineering Co., Ltd.

As it contains healthy brain tissue, it may result in immune responses against normal brain tissue, leading to autoimmune encephalitis, or inflammation of the brain (Polyzoidis and Ashkan, 2014).

  • Hepatitis
  • World
  • Market Size
  • Juno Therapeutics Inc.
  • Merck & Co., Inc.

You can easily book an appointment with one online.

  • Hepatitis
  • World
  • bioMerieux S.A.
  • Grifols, S.A.
  • Roche Group

THIS WAS DUE TO ONE LARGE DEAL SETTLED FOR $## BILLION.

  • Hepatitis
  • Therapy
  • World
  • Market Size
  • Gilead Sciences, Inc.

## Chikungunya Virus Infection ## Dengue Virus Infection ## Encephalitis ## Flavivirus Infection ## Hepatitis B Infection ## Hepatitis C Infection ## Human Papilloma Virus Infection ## Human T-lymphotropic Virus ## Resp

  • Hepatitis
  • HIV AIDS
  • United States
  • Company
  • ViroLogic, Inc.
  • Hepatitis C Virus Envelope Protein E2 - Companies Involved in Therapeutics Development
  • PIPELINE BY INTEGRATED BIOTHERAPEUTICS INC, H2 2018

Hepatitis C Virus Envelope Protein E2 - Pipeline Review, H2 2018 Summary According to the recently published report ’Hepatitis C Virus Envelope Protein E2 - Pipeline Review, H2 2018’; Hepatitis C Virus Envelope Protein E2 pipeline Target constitutes close to 12 molecules. Out of which approximately...

  • Hepatitis
  • United States
  • World
  • Product Initiative
  • Vaxart, Inc.
  • Clinical Trial profile. 88 Trial Title
  • Clinical Trial profile. 58 Trial Title

Hepatitis A Global Clinical Trials Review, H2, 2017 Summary GlobalData’s clinical trial report, “Hepatitis A Global Clinical Trials Review, H2, 2017" provides an overview of Hepatitis A clinical trials scenario. This report provides top line data relating to the clinical trials on Hepatitis A. Report includes an overview...

  • Hepatitis
  • Infectious Disease
  • World
  • Product Initiative
  • GlaxoSmithKline plc

The company utilizes patented platforms such as anti dengue virus technologies to develop cures for flaviviridae, chikungunya, hepatitis c, yellow fever, tick borne encephalitis, Japanese encephalitis, and others.

  • Hepatitis
  • Therapy
  • United States
  • World
  • Product Initiative
  • 09/22/2017: Bristol-Myers Squibb's Opdivo Receives FDA Approval for the Treatment of Hepatocellular Carcinoma Patients Previously Treated with Sorafenib

Opdivo is associated with the following Warnings and Precautions including: immune-mediated pneumonitis, colitis, hepatitis, endocrinopathies, nephritis and renal dysfunction, skin adverse reactions, encephalitis, other adverse reactions; infusion reactions; and embryo-fetal toxicity.

  • Hepatitis
  • Lung Cancer
  • Pharmaceutical
  • United States
  • Ono Pharmaceutical Co., Ltd.

One unit refers to one test kit.

  • Clinical Trial
  • Hepatitis
  • In Vitro Diagnostic Reagent
  • RNA
  • Abbott

Growth in molecular biology lines was driven by the ongoing fast-paced development of FilmArray®, and in particular the Gastrointestinal and Meningitis/ Encephalitis panels.

  • Clinical Trial
  • Hepatitis
  • Molecular Diagnostic
  • RNA
  • GlobalData's company
  • KIN-1400 - DRUG PROFILE
  • HEPATITIS B - PIPELINE BY TCM BIOTECH INTERNATIONAL CORP, H1 2018

## ## ## ## ## ## ## ## ## ## ## ## ## ## ## P I ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## P II ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## PC ## ## ## ## ## ## ## ## ## ## ## ##

  • Hepatitis
  • Research And Development
  • United States
  • Company
  • Product Initiative
  • HEPATITIS C - PIPELINE BY INOVIO PHARMACEUTICALS INC, H1 2018
  • HEPATITIS C - PIPELINE BY DEKK-TEC INC, H1 2018

The company utilizes patented platforms such as anti dengue virus technologies to develop cures for flaviviridae, chikungunya, hepatitis c, yellow fever, tick borne encephalitis, Japanese encephalitis, and others.

  • Antiviral
  • Hepatitis
  • Research And Development
  • Therapy
  • Bristol-Myers Squibb Company
  • Clinical Trial profile. 10 Trial Title
  • Clinical Trial profile. 81 Trial Title

Hepatitis A Global Clinical Trials Review, H1, 2016 Summary GlobalData's clinical trial report, “Hepatitis A Global Clinical Trials Review, H1, 2016" provides an overview of Hepatitis A clinical trials scenario. This report provides top line data relating to the clinical trials on Hepatitis A. Report includes an overview...

  • Hepatitis
  • Infectious Disease
  • Vaccine
  • World
  • Product Initiative
  • HEPATITIS B - PIPELINE BY THEVAX GENETICS VACCINE USA INC
  • HEPATITIS B - PIPELINE BY THERAVECTYS SA

LIN) ##. ##. ##. ## ## Mar ##, ## ##: Altimmune Provides an Update on Its Phase ## b Study of HepTcell Targeted Immunotherapy in Chronic Hepatitis B Infection ALTIMMUNE, INC., A CLINICAL-STAGE IMMUNOTHERAPEUTICS COMPANY, PROVIDED AN UPDATE ON ITS PHASE ##B STUDY OF HEPTCE

  • Biotech
  • Hepatitis
  • Pharmaceutical
  • Company
  • Product Initiative

AS OF MARCH 2003, THE DRUG CANDIDATE WAS IN PRECLINICAL STAGE FOR WEST NILE VIRUS INFECTIONS, JAPANESE ENCEPHALITIS, DENGUE FEVER, YELLOW FEVER, ST LOUIS ENCEPHALITIS, MURRAY VALLEY AND BANZAI VIRUSES.

  • Hepatitis
  • Lung Cancer
  • Therapy
  • United States
  • Product Initiative
  • HEPATITIS B - PIPELINE BY TCM BIOTECH INTERNATIONAL CORP, H2 2017
  • HEPATITIS B - PIPELINE BY THEVAX GENETICS VACCINE USA INC, H2 2017

## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ##

  • Biotech
  • Hepatitis
  • Infectious Disease
  • Vaccine
  • Arbutus Biopharma Corporation
  • HEPATITIS C - PIPELINE BY INOVIO PHARMACEUTICALS INC, H2 2017
  • VERDINEXOR - DRUG PROFILE

IBT' s vaccines and antibody therapeutics are used in the treatment of Filoviruses Ebola, Sudan, Hemorrhagic fevers, Marbur, Equine Encephalitis viruses and Chikungunya and Hepatitis C.

  • Antiviral
  • Hepatitis
  • United States
  • Product Initiative
  • Bristol-Myers Squibb Company
  • 5. ALL THE TRIALS INCLUDED ARE UNIQUE TRIALS.

Hoffmann-La Roche Ltd ## ## ## ## ## ## ## ## Bristol-Myers Squibb Company ## ## ## ## ## ## ## ## Merck & Co Inc ## ## ## ## ## ## ## ## Sanofi ## ## ## ## ## ## ## ## Novartis AG ## ## ## ## ## ## ## ## Bukwang Pharm Co Ltd ## ## ## ## ## ##

  • Clinical Trial
  • Hepatitis
  • Infectious Disease
  • World
  • GlaxoSmithKline plc

Antiviral activity was also observed against other flaviviruses such as the yellow fever virus and the tick-borne encephalitis virus (TBEV).

  • Hepatitis
  • Lymphoma
  • Monoclonal Antibody
  • Therapy
  • United States
  • Hepatitis C Virus (HCV) Envelope Protein E2 - Companies Involved in Therapeutics Development

IBT' s vaccines and antibody therapeutics find application in treating Filoviruses Ebola, Sudan, Hemorrhagic Fevers, Marburg, Equine Encephalitis viruses and Chikungunya and Hepatitis C.

  • Hepatitis
  • United States
  • World
  • Product Initiative
  • BioTherapeutics Inc.
  • Clinical Trial profile. 964 Trial Title
  • Clinical Trial profile. 1356 Trial Title

Hepatitis Global Clinical Trials Review, H2, 2015 Summary GlobalData's clinical trial report, “Hepatitis Global Clinical Trials Review, H2, 2015" provides an overview of Hepatitis clinical trials scenario. This report provides top line data relating to the clinical trials on Hepatitis. Report includes an overview of trial...

  • Clinical Trial
  • Drug Discovery And Development
  • Hepatitis
  • Pharmaceutical
  • World

Programmed Cell Death ## Ligand ## (PD L## or B## Homolog ## or CD##) - Pipeline Review, H## 2016 Reference Code: GMDHC##TDB Publication Date: October 2016 LIST OF FIGURES Introduction GLOBAL MARKETS DIRECT REPORT COVERAGE GLOBAL MARKETS DIRECT' S, ' PROGRAMMED CELL D

  • Hepatitis
  • Hospital
  • Oncology
  • Therapy
  • MedImmune, LLC
  • Sep 22, 2017: Bristol-Myers Squibb's Opdivo Receives FDA Approval for the Treatment of Hepatocellular Carcinoma Patients Previously Treated with Sorafenib

Opdivo is associated with the following Warnings and Precautions including: immune-mediated pneumonitis, colitis, hepatitis, endocrinopathies, nephritis and renal dysfunction, skin adverse reactions, encephalitis, other adverse reactions; infusion reactions; and embryo-fetal toxicity.

  • Cell Therapy
  • Hepatitis
  • North America
  • United States
  • Company